Phase 3 trials and drug labeling.
D002318:Cardiovascular Diseases / Q000188:drug therapy; D002319:Cardiovascular System / Q000187:drug effects*; D004282:Documentation; D004341:Drug Evaluation; D004348:Drug Labeling; D064420:Drug-Related Side Effects and Adverse Reactions; D006266:Health Education; D006801:Humans; D008499:Medical Records; D010380:Peer Review; D010600:Pharmacology; D011643:Publishing; D014481:United States; D014486:United States Food and Drug Administration